Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.55 USD | -1.08% | +0.52% | -41.85% |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
May. 28 | Cytokinetics Closes $500 Million Stock Offering | MT |
Financials (USD)
Sales 2024 * | 29.2M | Sales 2025 * | 75.05M | Capitalization | 5.57B |
---|---|---|---|---|---|
Net income 2024 * | -489M | Net income 2025 * | -482M | EV / Sales 2024 * | 189 x |
Net cash position 2024 * | 33.92M | Net cash position 2025 * | 417M | EV / Sales 2025 * | 68.6 x |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-11.1
x | Employees | 423 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.45% |
Latest transcript on Cytokinetics, Incorporated
1 day | -1.08% | ||
1 week | +0.52% | ||
Current month | +0.08% | ||
1 month | -24.54% | ||
3 months | -34.37% | ||
6 months | +44.62% | ||
Current year | -41.85% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 98-06-30 |
Kari Loeser
CMP | Compliance Officer | - | 21-10-31 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20-11-19 |
Edward Kaye
BRD | Director/Board Member | 75 | 16-05-19 |
Santo Costa
BRD | Director/Board Member | 78 | 10-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 0 M€ | 0.00% | - | |
0.39% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 48.51 | -1.24% | 2,530,227 |
24-05-30 | 49.12 | +2.63% | 2,476,461 |
24-05-29 | 47.86 | -0.73% | 3,316,115 |
24-05-28 | 48.21 | -0.19% | 3,762,066 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.85% | 5.57B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.67% | 21.96B | |
-8.93% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- CYTK Stock